| Medico Remedies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540937 |
NSE Symbol : MEDICO |
P/E(TTM) : 39.11 |
|
ISIN Demat : INE630Y01024 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.37 |
|
Book Value(₹) : 8.06 |
Market Cap(₹Cr) : 444.63 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 52.64 | 38.25 | 41.30 | 39.49 | 39.35 | 30.80 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 52.64 | 38.25 | 41.30 | 39.49 | 39.35 | 30.80 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.72 | 0.66 | 0.29 | 1.43 | 0.68 | 0.29 |
| Total Income | 54.36 | 38.91 | 41.60 | 40.91 | 40.03 | 31.09 |
| Total Expenditure | 49.92 | 35.43 | 34.64 | 36.38 | 36.94 | 27.99 |
| PBIDT | 4.44 | 3.48 | 6.96 | 4.54 | 3.09 | 3.10 |
| Interest | 0.24 | 0.28 | 0.49 | 0.28 | 0.21 | 0.18 |
| PBDT | 4.21 | 3.20 | 6.46 | 4.26 | 2.88 | 2.93 |
| Depreciation | 0.73 | 0.77 | 0.77 | 0.76 | 0.75 | 0.75 |
| Tax | 0.77 | 0.54 | 1.88 | 0.79 | 0.60 | 0.53 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.13 | 0.08 | -0.52 | 0.09 | -0.02 | 0.06 |
| Reported Profit After Tax | 2.57 | 1.82 | 4.34 | 2.62 | 1.55 | 1.58 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.57 | 1.82 | 4.34 | 2.62 | 1.55 | 1.58 |
| EPS (Unit Curr.) | 0.31 | 0.22 | 0.52 | 0.32 | 0.19 | 0.19 |
| EPS (Adj) (Unit Curr.) | 0.31 | 0.22 | 0.52 | 0.32 | 0.19 | 0.19 |
| Calculated EPS (Unit Curr.) | 0.31 | 0.22 | 0.52 | 0.32 | 0.19 | 0.19 |
| Calculated EPS (Adj) (Unit Curr.) | 0.31 | 0.22 | 0.52 | 0.32 | 0.19 | 0.19 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.24 | 0.88 | 2.09 | 1.26 | 0.75 | 0.76 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.24 | 0.88 | 2.09 | 1.26 | 0.75 | 0.76 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 8.43 | 9.10 | 16.85 | 11.50 | 7.85 | 10.06 |
| PBDTM(%) | 8.00 | 8.37 | 15.64 | 10.79 | 7.32 | 9.51 |
| PATM(%) | 4.88 | 4.76 | 10.51 | 6.63 | 3.94 | 5.13 |